Shopping Cart
Remove All
Your shopping cart is currently empty
Kisspeptin-10, human TFA is a potent vasoconstrictor and angiogenesis inhibitor. Kisspeptin-10, human TFA acts as a tumor metastasis suppressor via its receptor GPR54. Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development. Kisspeptin-10/GPR54 signaling induces osteoblast differentiation via NFATc4-mediated BMP2 expression

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $115 | In Stock | In Stock | |
| 5 mg | $385 | In Stock | In Stock | |
| 10 mg | $577 | In Stock | In Stock | |
| 25 mg | $926 | In Stock | In Stock | |
| 50 mg | $1,260 | In Stock | In Stock | |
| 100 mg | $1,680 | In Stock | In Stock |
| Description | Kisspeptin-10, human TFA is a potent vasoconstrictor and angiogenesis inhibitor. Kisspeptin-10, human TFA acts as a tumor metastasis suppressor via its receptor GPR54. Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development. Kisspeptin-10/GPR54 signaling induces osteoblast differentiation via NFATc4-mediated BMP2 expression |
| In vitro | KP-10-treatment significantly increased the expression of osteogenic genes, including mRNA and protein levels of BMP2, in C3H10T1/2 cells.?Moreover, KP-10 induced BMP2-luc activity and increased phosphorylation of Smad1/5/9.?In addition, NFATc4 specifically mediated KP-10-induced BMP2 gene expression.?However, KP-10 treatment did not induce expression of the BMP2 and Runx2 genes in GPR54-/- cells.?To examine whether KP-10 induced secretion of BMP2 to the culture medium, we used the conditioned-medium (C.M) of KP-10 treated medium on C3H10T1/2 cells.?Dlx5 and Runx2 expressions were higher in GPR54-/- cells treated with C.M than in those treated with KP-10[1]. |
| Molecular Weight | 1416.46 |
| Formula | C63H83N17O14.C2HF3O2 |
| Smiles | CC([H])(C[C@](N=C(C/N=C([C@](CC1=CC=CC=C1)(N=C([C@](CO)(N=C([C@](CC(O)=N)(N=C([C@](CC2=CNC3=CC=CC=C23)(N=C([C@](CC(O)=N)(N=C([C@]([H])(CC4=CC=C(C=C4)O)N)O)[H])O)[H])O)[H])O)[H])O)[H])\O)O)(C(O)=N[C@@](CCCNC(N)=N)(C(O)=N[C@@](CC5=CC=CC=C5)(C(O)=N)[H])[H])[H])C.O=C(O)C(F)(F)F |
| Relative Density. | 1.31g/cm3 |
| Color | White |
| Appearance | solid |
| Sequence | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 |
| Sequence Short | YNWNSFGLRF-NH2 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | H2O: 4 mg/mL (2.82 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
H2O
| |||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.